Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SARS-CoV-2 vaccine + influenza vaccine
- Development stage
- Unknown
- Lead developer
- IRCCS Fondazione Ca’ Granda Ospedale Maggiore Policlinico
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
SARS-CoV-2 vaccine + influenza vaccine (Fondazione IRCCS Ca' Granda) refers to the co-administration or sequential use of vaccines targeting COVID-19 and seasonal influenza, specifically within the research framework of the Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico. This combination is primarily studied in the Tfh-CKD clinical trial, which evaluates the impact of chronic kidney failure and hemodialysis on the humoral immune response. The study focuses on the regulation of T follicular helper (Tfh) cells and the subsequent generation of protective antibodies in immunocompromised populations compared to healthy controls. The specific vaccine products used are typically standard-of-care biologicals approved for the prevention of their respective viral infections.
- Other names
- SARS-CoV-2 vaccine-Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico-influenzaInfluenza vaccine and SARS-CoV-2 vaccine co-administration
02
Targets
SARS-CoV-2 spikeHA (Hemagglutinin)
Beyond the preview
Go deeper on SARS-CoV-2 vaccine + influenza vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SARS-CoV-2 vaccine + influenza vaccine.